Recombinetics is a renowned brand that specializes in animal gene editing and associated applied technologies. With a focus on biomedical research, regenerative medicine, and animal agriculture, Recombinetics leads the way in this field. Their proprietary gene editing platform allows them to commercialize and deploy technologies through four subsidiaries, making a significant impact on human health and adding value to farm animals.

The facts speak for themselves: there are currently 113,000 people on the U. S. Additionally, 90% of all clinical trials fail, and 1.

5 billion smallholders are raising unproductive animals. Through their subsidiaries, Recombinetics offers groundbreaking technology and life-changing solutions. Their expertise in animal gene editing is applied in three key areas: regenerative medicine, preclinical research, and precision breeding.

From addressing the organ shortage crisis through xenotransplantation to producing healthier and more sustainable farm animals, Recombinetics is committed to making a positive impact. With notable news such as their merger with Makana Therapeutics to accelerate transplantation, Recombinetics is at the forefront of innovation in their industry. Investing in Recombinetics means contributing to a world-changing cause.

Contact them today to find out how you can make a difference